scPharmaceuticals Inc (SCPH)

Etorro trading 970x250
scPharmaceuticals Inc (SCPH) Logo

About scPharmaceuticals Inc

scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company’s lead product candidate is Furoscix that consists of proprietary buffered formulation of furosemide, which is delivered through the SmartDose drug delivery system for treatment of congestion in decompensated heart failure patients. Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for treating infections caused by gram-negative organisms. The company has a development agreement with West Pharmaceutical Services, Inc. to incorporate SmartDose drug delivery system with Furoscix. The company was founded in 2013 and is headquartered in Burlington, Massachusetts. Address: 2400 District Avenue, Burlington, MA, United States, 01803

scPharmaceuticals Inc News and around…

Latest news about scPharmaceuticals Inc (SCPH) common stock and company :

scPharmaceuticals to Participate in Two Upcoming Investor Conferences
20 Dec, 2021 Yahoo! Finance

BURLINGTON, Mass., Dec. 20, 2021 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker, president & chief executive officer, will participate virtually in two upcoming investor conferences. Events: 11th Annual LifeSci Partners Corporate Access Event 2022Wednesday, January 5 – Friday, Jan

Is scPharmaceuticals (NASDAQ:SCPH) Using Debt In A Risky Way?
22 Nov, 2021 Yahoo! Finance

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

scPharmaceuticals Inc. Reports Third Quarter 2021 Financial Results and Provides Business Update
09 Nov, 2021 Yahoo! Finance

All additional testing of devices manufactured on the planned commercial line, as required by the FDA, has been successful to date FUROSCIX® NDA resubmission anticipated for Q1 2022 due to COVID-19 related global supply chain logistics interruptions and travel restrictions Revised NDA resubmission timeline is not expected to have an impact on anticipated Q4 2022 commercial launch of FUROSCIX, if approved Ended Q3 with cash, cash equivalents, restricted cash and investments of $85.0 million, suff

scPharmaceuticals to Present at the Jefferies London Healthcare Conference
02 Nov, 2021 Yahoo! Finance

BURLINGTON, Mass., Nov. 02, 2021 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker, president & chief executive officer, is scheduled to present at the Jefferies London Healthcare Conference, which is being held in-person on November 16-17 and virtually November 18-19. Mr. Tucker is

scPharmaceuticals Inc. Presents Late-breaking FREEDOM-HF Study Data at the Heart Failure Society of America Annual Scientific Meeting 2021
10 Sep, 2021 FinancialContent
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2021
09 Sep, 2021 FinancialContent

Upgrades According to Benchmark, the prior rating for TopBuild Corp (NYSE:BLD) was changed from Hold to Buy. In the ...

scPharmaceuticals to Present at the Virtual H.C. Wainwright 23rd Annual Global Investment Conference
01 Sep, 2021 FinancialContent
Are Institutions Heavily Invested In scPharmaceuticals Inc.'s (NASDAQ:SCPH) Shares?
23 Aug, 2021 Yahoo! Finance

Every investor in scPharmaceuticals Inc. ( NASDAQ:SCPH ) should be aware of the most powerful shareholder groups...

The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck
19 Aug, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline
18 Aug, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

scPharmaceuticals Inc. Reports Second Quarter 2021 Financial Results and Provides Business Update
11 Aug, 2021 FinancialContent
Analysts Predict 25% Gains Ahead For The Holdings of FDM
06 Aug, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the First Trust Dow Jones Select MicroCap Index Fund ETF (FDM), we found that the implied analyst target price for the ETF based upon its underlying holdings is $75.32 per unit.

The Daily Biotech Pulse: ScPharma's Positive Data, Lilly Goes Shopping, LeMaitre Pre-Announces Q2 Revenues
14 Jul, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

26 Stocks Moving in Wednesday's Pre-Market Session
14 Jul, 2021 FinancialContent

Gainers Yunhong CTI Ltd. (NASDAQ: CTIB) shares rose 35.6% to $3.54 in pre-market trading after jumping around 12% on ...

scPharma's Furoscix Can Potentially Cut Hospital Admission/Readmission Costs For Heart Failure Patients
14 Jul, 2021 FinancialContent

scPharmaceuticals Inc(NASDAQ: SCPH)announced top-line resultsfrom its FREEDOM-HF study evaluating overall and heart ...

12 Health Care Stocks Moving In Tuesday's After-Market Session
13 Jul, 2021 FinancialContent

Gainers scPharmaceuticals (NASDAQ:SCPH) shares increased by 9.27% to $7.19 during Tuesday's after-market session. At the close, ...

scPharmaceuticals Inc. Announces Positive Top-Line Results from FREEDOM-HF Study
13 Jul, 2021 FinancialContent
58 Biggest Movers From Yesterday
02 Jul, 2021 FinancialContent

Gainers The Glimpse Group, Inc. (NASDAQ: VRAR) shares jumped 152.3% to settle at $17.66 on Thursday after the company priced its ...

12 Health Care Stocks Moving In Thursday's Intraday Session
01 Jul, 2021 FinancialContent

Gainers Alterity Therapeutics (NASDAQ:ATHE) shares increased by 60.0% to $2.08 during Thursday's regular session. Trading volume for ...

scPharmaceuticals Inc. Announces Receipt of Written Minutes from Type C Meeting with the FDA Regarding Development of FUROSCIX®
01 Jul, 2021 FinancialContent
Implied FDM Analyst Target Price: $74
24 Jun, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the First Trust Dow Jones Select MicroCap Index Fund ETF (FDM), we found that the implied analyst target price for the ETF based upon its underlying holdings is $74.36 per unit.

12 Health Care Stocks Moving In Monday's After-Market Session
21 Jun, 2021 FinancialContent

Gainers Adial Pharmaceuticals (NASDAQ:ADIL) shares moved upwards by 17.77% to $3.38 during Monday's after-market session. This ...

Oversold Conditions For scPharmaceuticals (SCPH)
17 Jun, 2021 FinancialContent

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100..

scPharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
19 May, 2021 FinancialContent
scPharmaceuticals Inc. Reports First Quarter 2021 Financial Results and Provides Business Update
12 May, 2021 FinancialContent
The Daily Biotech Pulse: FDA Approvals For Merck, Pacira And Zealand, Roche-Regeneron Ace Late-Stage COVID-19 Study, AlloVir Appoints Gilead Virology Chief As CEO
23 Mar, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

scPharmaceuticals Inc. Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
23 Mar, 2021 FinancialContent
scPharmaceuticals to Present in Two Upcoming Investor Conferences
25 Feb, 2021 FinancialContent
What Is The Ownership Structure Like For scPharmaceuticals Inc. (NASDAQ:SCPH)?
24 Feb, 2021 Yahoo! Finance

Every investor in scPharmaceuticals Inc. ( NASDAQ:SCPH ) should be aware of the most powerful shareholder groups. Large...

ScPharmaceuticals Sees US Application Submission For Furoscix In Q3
23 Feb, 2021 FinancialContent

ScPharmaceuticals Inc(NASDAQ:SCPH) announced that after the Type A meeting with the FDA, theagency does not require ...

scPharmaceuticals Inc (SCPH) is a NASDAQ Common Stock listed in , ,

970x250